FlyCap and the founder have sold Bio2You to INVL Baltic Sea Growth Fund
Latvia-based growth capital fund FlyCap has sold its 39% stake in Bio2You to INVL Baltic Sea Growth Fund. The remaining 61% of the shares was sold by the founder and CEO of the company. As a result of this transaction, INVL Baltic Sea Growth Fund now controls 100% of Bio2You.
Bio2You is a cosmetics manufacturer based in Latvia. The company offers private label and contract manufacturing services, as well as selling products under their own brand. It produces skin, body, hair and oral care products, and other bath and shower items (bath salts and bath bombs), as well as their own soap base. The brand has a particular focus on anti-aging products.
INVL Baltic Sea Growth Fund is a closed-end investment fund intended for professional investors and is one of the largest private equity investment funds in the Baltic region. It is focused on growth capital, buy-out, and buy-and-build investments.
Oaklins’ team in Latvia advised the sellers through all stages of this transaction.
Talk to the deal team
Reinholds R. Razums
Ricotto has been acquired by Sitra Group
Ricotto S.r.l. has joint Sitra Group, a Belgium-based and PE-backed international logistic and transportation group.Learn more
M80 Partners has acquired Luminis
Belgian private equity fund M80 has acquired a majority stake in Luminis. M80 offers to software and technology company Luminis the opportunity to further expand its strategy and market position internationally. Luminis becomes part of a platform that also includes XPLUS, a Belgian expert in enterprise IT architecture. M80 plans to make further selective acquisitions in Europe in the coming months with the aim of bringing together a portfolio of best-in-class digital transformation specialists.Learn more
Spice Private Equity Ltd. has had a fairness opinion conducted on a public tender offer by GP Investments
On 14 July 2022, GP Swiss Ltd., a subsidiary of GP Investments, published a public tender offer for all publicly held registered shares of Spice Private Equity Ltd. (Spice). The independent members of the Board of Directors of Spice have had a fairness opinion conducted on the financial adequacy of this public tender offer. The offer price for each Spice share was US$16.25 net in cash. Following a successful offer, GP Investment intends to delist the stock from the SIX Swiss Stock Exchange.Learn more